GeoVax Labs, Inc. - Common Stock - Nakit Akışı (NASDAQ:GOVX)

Financials

İşletme faaliyetlerinden elde edilen nakit -2.75 M-11.2 M-19.03 M-25.17 M-24.68 M-21.47 M -19.05 M Yatırım faaliyetlerinden elde edilen nakit -156.79 K-47.72 K-134.26 K-48.95 K-20.65 K-27.61 K -10.72 K Finansman faaliyetlerinden elde edilen nakit 12.51 M12.78 M35.35 M4.06 M23.75 M19.08 M 12.89 M Serbest nakit akışı -2.75 M-11.2 M-19.03 M-25.17 M-24.68 M-21.47 M -19.05 M

GeoVax Labs, Inc. - Common Stock

GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated.

Haberler

GeoVax Labs, Inc. (GOVX) Discusses Building a Resilient Infectious Disease Preparedness Strategy Focused on Ebola, Marburg, Hantavirus, and Mpox Transcript

GOVX

Financials